Skip to content
10-Q

Quarterly Report

AVANOS MEDICAL, INC. AVNS

0001606498-25-000131

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 46.42M sh
Shares Diluted Q3 2025 · Sep 30, 2025 46.4M sh
Shares Diluted Q3 2025 · Sep 30, 2025 46.3M sh
Shares Diluted Q3 2025 · Sep 30, 2024 46.6M sh
Shares Diluted Q3 2025 · Sep 30, 2024 46.5M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $3M
Stock Repurchased Q3 2025 · Sep 30, 2024 $12.7M
Capex Q3 2025 · Sep 30, 2025 $24.7M
Capex Q3 2025 · Sep 30, 2024 $13M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $46.5M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $42.8M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $70.5M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $107.7M
Stockholders Equity Q3 2025 · Sep 30, 2025 $778M
Stockholders Equity Q3 2025 · Dec 31, 2024 $828.5M
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.23B
Current Liabilities Q3 2025 · Sep 30, 2025 $147.9M
Current Liabilities Q3 2025 · Dec 31, 2024 $165.9M
Total Liabilities Q3 2025 · Sep 30, 2025 $289.7M
Total Liabilities Q3 2025 · Dec 31, 2024 $325.7M
Current Assets Q3 2025 · Sep 30, 2025 $351.4M
Current Assets Q3 2025 · Dec 31, 2024 $393.4M
Total Assets Q3 2025 · Sep 30, 2025 $1.07B
Total Assets Q3 2025 · Dec 31, 2024 $1.15B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.03
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.55
Eps Diluted Q3 2025 · Sep 30, 2024 $0.09
Eps Diluted Q3 2025 · Sep 30, 2024 $0.11
Eps Basic Q3 2025 · Sep 30, 2025 −$0.03
Eps Basic Q3 2025 · Sep 30, 2025 −$1.55
Eps Basic restated Q3 2025 · Sep 30, 2024 $0.09
Eps Basic Q3 2025 · Sep 30, 2024 $0.11
Sga Expense Q3 2025 · Sep 30, 2025 $77.6M
Sga Expense Q3 2025 · Sep 30, 2025 $236.8M
Sga Expense Q3 2025 · Sep 30, 2024 $74.3M
Sga Expense Q3 2025 · Sep 30, 2024 $238.8M
Rd Expense Q3 2025 · Sep 30, 2025 $6M
Rd Expense Q3 2025 · Sep 30, 2025 $17.2M
Rd Expense Q3 2025 · Sep 30, 2024 $7.2M
Rd Expense Q3 2025 · Sep 30, 2024 $20.5M
Net Income Q3 2025 · Sep 30, 2025 −$1.4M
Net Income Q3 2025 · Sep 30, 2025 −$71.6M
Net Income Q3 2025 · Sep 30, 2024 $4.3M
Net Income Q3 2025 · Sep 30, 2024 $5.2M
Operating Income Q3 2025 · Sep 30, 2025 $100K
Operating Income Q3 2025 · Sep 30, 2025 −$64.1M
Operating Income Q3 2025 · Sep 30, 2024 $12M
Operating Income Q3 2025 · Sep 30, 2024 $22.3M
Gross Profit Q3 2025 · Sep 30, 2025 $86M
Gross Profit Q3 2025 · Sep 30, 2025 $267.9M
Gross Profit Q3 2025 · Sep 30, 2024 $92.9M
Gross Profit Q3 2025 · Sep 30, 2024 $283.3M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $91.8M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $252.4M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $77.5M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $224.9M
Revenue Q3 2025 · Sep 30, 2025 $177.8M
Revenue Q3 2025 · Sep 30, 2025 $520.3M
Revenue Q3 2025 · Sep 30, 2024 $170.4M
Revenue Q3 2025 · Sep 30, 2024 $508.2M